Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 16, 2019 to June 5, 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- LLNA was considered not to be suitable for the test substance.
Test material
- Reference substance name:
- Sulfonic acids, C16-alkane hydroxy and C16-alkene, potassium salts
- Cas Number:
- 2210238-42-7
- IUPAC Name:
- Sulfonic acids, C16-alkane hydroxy and C16-alkene, potassium salts
- Test material form:
- liquid
- Remarks:
- Colorless Clear Liquid
- Details on test material:
- Expiration date: August 2021
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Guinea pig, Hartley (Slc:Hartley, closed colony), SPF
- Age at study initiation: 5 Weeks old
- Weight at study initiation: 300–355 g
- Housing: The animals were housed 5 or 6 per cage during the quarantine and acclimatization period, and 5 per cage during the experimental period.
- Diet: Pellet diet LRC4 (Lot No. 190207, 190305; Oriental Yeast Co., Ltd.) was offered ad libitum.
- Water: Municipal tap water filtered through a 5-µm cartridge filter and sterilized with an ultraviolet sterilizer was offered ad libitum through an automatic water-supply system.
- Acclimation period: For 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: Actual values, 21.9°C-25.2°C (Set value, 23°C; acceptable range, 20°C-26°C)
- Relative humidity: Actual values, 43.2%-69.7% (Set value, 50%; acceptable range, 30%-70%)
- Ventilation frequency: 12 Times /hour
- Light period: 12 Hours/day (on at 6:00 AM, off at 6:00 PM)
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Remarks:
- For Topical induction: Water for injection
- Concentration / amount:
- For Intradermal induction: 0.1 w/w%
For Topical induction: 1 w/w% - Day(s)/duration:
- For Intradermal induction: 7 days
For Topical induction: 48hrs - Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Water for injection
- Concentration / amount:
- 0.3, 0.1, and 0.05 w/w%
0.1 mL - Day(s)/duration:
- 24 hours
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 10 animals in the test-substance sensitization group
5 animals in the control group - Details on study design:
- RANGE FINDING TESTS: In a non-GLP preliminary study, skin reaction to the intraderrnal injection of the test substance at 0.5, 0.3, 0.1, 0.05, 0.03 and 0.01 w/w% was as follows: Score-4 necrosis with Score-2 edema at 0.5 and 0.3w/w%; Score-1 erytherna at 0.1 and 0.05 w/w%; and no reaction at 0.03 w/w% and lower. The results for occlusive application at 5, 3, 1, 0.5, 0.3 and 0.1 w/w% were as follows: Score-4 eschar with Score-2 edema at 5 and 3 w/w%; Score-2 erythema with Score-1 edema at 1 w/w%; Score-1 erythema at 0.5 w/w%; and no reaction at 0.3 w/w% and lower.
Based on these results, 0.1 and 1 w/w% was selected for intradermal and topical induction, respectively. For challenge, 3 concentrations of 0.3, 0.1, and 0.05 w/w% were selected.
MAIN STUDY
1. INDUCTION EXPOSURE
For intradermal induction of the test-substance group, 0.1 mL each of the following 3 test materials were intradermally injected into 2 sites of the shaved skin of the dorsal neck of the guinea pigs:
A, An emulsion of equal volumes (v/v) of FCA and physiological saline;
B, Test-substance solution at 0.1 w/w% (vehicle: physiological saline);
C, An emulsion of equal volumes (v/v) of 0.2-w/w¾ test-substance solution (vehicle: physiological saline) and FCA.
For contact sensitization, 0.2 mL of the test-substance solution at 1 w/w% (vehicle: water for injection) was impregnated into a 2×4-cm piece of lint cloth on the day 7, followed by occlusive application to the sites for intradermal injection for 48 hours.
The control animals were treated in the same manner with the vehicles for each sensitization.
2. CHALLENGE EXPOSURE
For challenge, 0.1 mL each of the test-substance solutions at 0.3, 0.1, 0.05 w/w% (vehicle: water for injection) was impregnated into 1.5×1.5-cm pieces of lint cloth on the day 21 of the sensitization, and 24 hour occlusive application was made on the right and left lateral region.
Observation of skin reaction was performed 24 and 48 hours after patch removal. - Positive control substance(s):
- not required
Results and discussion
- Positive control results:
- see attachements
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.3, 0.1, and 0.05 w/w%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No abnormalities were found in the general condition of the animals, and weight gain was satisfactory.
- Remarks on result:
- other: see attachments
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0.3, 0.1, and 0.05 w/w%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No abnormalities were found in the general condition of the animals, and weight gain was satisfactory.
- Remarks on result:
- other: see attachments
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 0.3, 0.1, and 0.05 w/w%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No abnormalities were found in the general condition of the animals, and weight gain was satisfactory.
- Remarks on result:
- other: see attachments
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.3, 0.1, and 0.05 w/w%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No abnormalities were found in the general condition of the animals, and weight gain was satisfactory.
- Remarks on result:
- other: see attachments
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0.3, 0.1, and 0.05 w/w%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No abnormalities were found in the general condition of the animals, and weight gain was satisfactory.
- Remarks on result:
- other: see attachments
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 0.3, 0.1, and 0.05 w/w%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No abnormalities were found in the general condition of the animals, and weight gain was satisfactory.
- Remarks on result:
- other: see attachments
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on the above results, the test substance is considered to have no skin-sensitization potential under the conditions of this study.
- Executive summary:
The skin-sensitization potential of C16K was investigated by the guinea-pig maximization-test method.
A total of 15 animals were used as follows: 10 animals in the test-substance sensitization group and 5 animals in the control group.
For intradermal induction of the test-substance sensitization group, 0.1 mL each of the following was intradermally injected into 2 sites of the cervical region: Emulsion of equal volumes of Freund's complete adjuvant (FCA) and physiological saline, Test-substance solution at 0.1 w/w% (vehicle: physiological saline), and Emulsion of equal volumes of the test-substance solution at 0.2 w/w% (vehicle: physiological saline) and FCA. For topical induction of the test-substance sensitization group, a 2x4-cm piece of lint, impregnated with 0.2 mL of the 1-w/w% test-substance solution (vehicle: water for injection), was occlusively applied onto the same site as the intradermal injection, and kept for 48 hours. The control animals were treated in the same manner with the vehicles for each induction. For challenge, 0.1 mL each of the test-substance solutions at 0.3, 0.1, and 0.05 w/w% was impregnated into a 1.5x1.5-cm piece of lint on the day 21 of the induction, and 24-hour occlusive application was made on the lateral region.
Assessment of skin reaction was performed 24 and 48 hours after patch removal for challenge.
As results, no skin reaction was induced by any formulation for challenge in the test-substance sensitization group or control group.
No animals showed any abnormalities in the general condition, and body weights increased in the experimental period.
Based on the above results, the test substance is considered to have no skin-sensitization potential under the conditions of this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.